Covered recipient · General Payments record
BROOKE MARTIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,311.26
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $297.64 | 12 |
| Consulting Fee | $29.56 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $142.05 | 4 |
| Retrophin, Inc. | $49.03 | 3 |
| Lilly USA, LLC | $33.84 | 1 |
| ADMA BioManufacturing LLC | $29.56 | 1 |
| GlaxoSmithKline, LLC. | $21.92 | 1 |
| Lundbeck LLC | $19.29 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $18.17 | 1 |
| Acerta Pharma LLC | $13.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ADMA BioManufacturing LLC | $29.56 | 04/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1149639444 | CMS |
| Amgen Inc. | $5.79 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115905079 | CMS |
| Amgen Inc. | $5.26 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115905084 | CMS |
| Amgen Inc. | $121.86 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115905099 | CMS |
| Amgen Inc. | $9.14 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115905091 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.34 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104581620 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $18.17 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141521523 | CMS |
| GlaxoSmithKline, LLC. | $21.92 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116476938 | CMS |
| Lilly USA, LLC | $33.84 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135554180 | CMS |
| Lundbeck LLC | $19.29 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146056609 | CMS |
| Travere Therapeutics, Inc. | $14.01 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149925418 | CMS |
| Travere Therapeutics, Inc. | $13.96 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149925414 | CMS |
| Travere Therapeutics, Inc. | $21.06 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149925422 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.